Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark

BSE2049.7559.15 (+2.97 %)

PREV CLOSE ( ) 1990.60

OPEN PRICE ( ) 1990.60

BID PRICE (QTY) 2050.05 (37)

OFFER PRICE (QTY) 2051.85 (3)

VOLUME 15400

TODAY'S LOW / HIGH ( )1990.60 2055.15

52 WK LOW / HIGH ( )1274.7 2286.15

NSE2050.8059.9 (+3.01 %)

PREV CLOSE( ) 1990.90

OPEN PRICE ( ) 1990.90

BID PRICE (QTY) 2050.50 (41)

OFFER PRICE (QTY) 2050.80 (14)

VOLUME 717263

TODAY'S LOW / HIGH( ) 1990.90 2055.20

52 WK LOW / HIGH ( )1275.5 2284.8

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

13992.09

5691.87

8684.51

14412.46

13824.75

Adjustment

9820.14

10098.14

14719.63

7871.08

6448.18

Changes In working Capital

-25286.92

-7969.53

-10744.81

-5612.61

-3858.38

Cash Flow after changes in Working Capital

-1474.69

7820.48

12659.33

16670.93

16414.55

Cash Flow from Operating Activities

-8275.95

-2654.44

6253.92

11086.52

11312.13

Cash Flow from Investing Activities

20.94

45608.93

-5284.91

-3332.80

-6752.36

Cash Flow from Financing Activities

7870.45

-39061.27

-774.56

-5204.91

-4417.79

Net Cash Inflow / Outflow

-384.56

3893.22

194.45

2548.81

141.98

Opening Cash & Cash Equivalents

16582.70

14430.26

14105.26

11380.95

11102.75

Cash & Cash Equivalent on Amalgamation / Take over / Merger

6.68

Cash & Cash Equivalent of Subsidiaries under liquidations

-1917.57

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

558.93

176.79

123.87

175.50

136.22

Closing Cash & Cash Equivalent

16757.07

16582.70

14430.26

14105.26

11380.95